1298662

John R. Vanderzyl, M.D. — FEI 3042029869

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 9, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Sugar Land, TX (United States)

Additional Details

Clinical Investigator (CI)